US Healthcare contract manufacturing Market

ID: MRFR/HS/18112-HCR
100 Pages
Satyendra Maurya
Last Updated: April 06, 2026
United States Healthcare contract manufacturing Market Research Report: Size, Share, Trend Analysis - Growth Outlook & Industry Forecast 2025 To 2035
US Healthcare contract manufacturing Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)4.42%
2024 Market Size$ 23 Billion
2025 Market Size$ 24.02 Billion
2035 Market Size$ 37 Billion
Key Players
Lonza Group
Catalent
Thermo Fisher Scientific
Baxter International
Fujifilm Diosynth Biotechnologies
Samsung Biologics
Trends
  • Rising Demand for Outsourced Services
  • Technological Advancements
  • Regulatory Compliance and Quality Assurance
Opportunities
  • Rising Regulatory Demands
  • Expansion of Biopharmaceuticals
  • Increasing Focus on Cost Efficiency
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Food, Beverages & Nutrition, BY Service Type (USD Billion)
      1. 4.1.1 Contract Manufacturing
      2. 4.1.2 Contract Packing
      3. 4.1.3 Contract Development
    2. 4.2 Food, Beverages & Nutrition, BY Product Type (USD Billion)
      1. 4.2.1 Pharmaceuticals
      2. 4.2.2 Biologics
      3. 4.2.3 Medical Devices
      4. 4.2.4 Nutraceuticals
    3. 4.3 Food, Beverages & Nutrition, BY End User (USD Billion)
      1. 4.3.1 Pharmaceutical Companies
      2. 4.3.2 Biotechnology Firms
      3. 4.3.3 Medical Device Companies
      4. 4.3.4 Research Institutions
    4. 4.4 Food, Beverages & Nutrition, BY Process Type (USD Billion)
      1. 4.4.1 Formulation Development
      2. 4.4.2 Packaging Solutions
      3. 4.4.3 Manufacturing Services
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Lonza Group (CH)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Catalent (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Thermo Fisher Scientific (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Baxter International (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Fujifilm Diosynth Biotechnologies (JP)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Samsung Biologics (KR)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Recipharm (SE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 WuXi AppTec (CN)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Aenova Group (DE)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY SERVICE TYPE
    3. 6.3 US MARKET ANALYSIS BY PRODUCT TYPE
    4. 6.4 US MARKET ANALYSIS BY END USER
    5. 6.5 US MARKET ANALYSIS BY PROCESS TYPE
    6. 6.6 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
    9. 6.9 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
    11. 6.11 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
    12. 6.12 FOOD, BEVERAGES & NUTRITION, BY SERVICE TYPE, 2024 (% SHARE)
    13. 6.13 FOOD, BEVERAGES & NUTRITION, BY SERVICE TYPE, 2024 TO 2035 (USD Billion)
    14. 6.14 FOOD, BEVERAGES & NUTRITION, BY PRODUCT TYPE, 2024 (% SHARE)
    15. 6.15 FOOD, BEVERAGES & NUTRITION, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
    16. 6.16 FOOD, BEVERAGES & NUTRITION, BY END USER, 2024 (% SHARE)
    17. 6.17 FOOD, BEVERAGES & NUTRITION, BY END USER, 2024 TO 2035 (USD Billion)
    18. 6.18 FOOD, BEVERAGES & NUTRITION, BY PROCESS TYPE, 2024 (% SHARE)
    19. 6.19 FOOD, BEVERAGES & NUTRITION, BY PROCESS TYPE, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY SERVICE TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Billion)
      3. 7.2.3 BY END USER, 2025-2035 (USD Billion)
      4. 7.2.4 BY PROCESS TYPE, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Healthcare contract manufacturing Market Segmentation

US Healthcare contract manufacturing Market By Service Type (USD Billion, 2025-2035)

  • Contract Manufacturing
  • Contract Packing
  • Contract Development

US Healthcare contract manufacturing Market By Product Type (USD Billion, 2025-2035)

  • Pharmaceuticals
  • Biologics
  • Medical Devices
  • Nutraceuticals

US Healthcare contract manufacturing Market By End User (USD Billion, 2025-2035)

  • Pharmaceutical Companies
  • Biotechnology Firms
  • Medical Device Companies
  • Research Institutions

US Healthcare contract manufacturing Market By Process Type (USD Billion, 2025-2035)

  • Formulation Development
  • Packaging Solutions
  • Manufacturing Services

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.